Search results
Results From The WOW.Com Content Network
In community samples, cutoff scores for likely dementia have ranged from 3.3 and above to 3.6 and above, while in patient samples the cutoff scores have ranged from 3.4 and above to 4.0 and above. To improve the detection of dementia, the IQCODE can be used in combination with the Mini-Mental State Examination.
June 11, 2024 at 3:25 AM. A new model could spot signs of dementia years before diagnosis, according to new research. Bisual Studio/ Stocksy. A new machine learning model can predict the eventual ...
Psychological therapies which are considered as potential treatments for dementia include music therapy, [5] reminiscence therapy, [6] cognitive reframing for caretakers, [7] validation therapy, [8] and mental exercise. [9] Interventions may be used in conjunction with pharmaceutical treatment and can be classified within behavior, emotion ...
The main objective outcome for rehabilitation is to assist in regaining physical abilities and improving performance. [1] [2] Three common neuropsychological problems treatable with rehabilitation are attention deficit/hyperactivity disorder (ADHD), [3] concussion, [4] and spinal cord injury. [1] Rehabilitation research and practices are a ...
Alzheimer's disease ( AD) is a neurodegenerative disease that usually starts slowly and progressively worsens, [2] and is the cause of 60–70% of cases of dementia. [2] [15] The most common early symptom is difficulty in remembering recent events. [1] As the disease advances, symptoms can include problems with language, disorientation ...
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
Integrative reminiscence therapy is a process in which individuals attempt to accept negative events in the past, resolve past conflicts, reconcile the discrepancy between ideals and reality, identify continuity between past and present, and find meaning and worth in life. [12]
Patients treated with the drug had a median progression-free survival of 16.6 months, compared to 8.1 months for those on chemotherapy. Novartis' drug tops chemotherapy in untreated lung cancer ...